Cencora (COR) said Wednesday it agreed to acquire Retina Consultants of America from private equity firm Webster Equity Partners for about $4.6 billion in cash, as the drug distributor looks to ...

Cencora will buy Retina Consultants of America from private-equity firm Webster Equity Partners for $4.6 billion, the drug distributor said on Wednesday, beefing up its presence in the market for ...

CONSHOHOCKEN, Pa., May 22, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of ...

Cencora is rolling out Accelerate Pharmacy Solutions, which brings together Cencora’s suite of pharmacy and supply chain solutions, to deliver an enhanced customer experience and integrated ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

Cencora’s low-cost model and negative net working capital ensure resilience. Find out why COR stock’s competitive advantages lead to consistent cash flow.

Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance, the second time the pharmacy chain has reduced its stake in the company this year as it looks to free up ...